Category Archives: Social Media

Looking Beyond Patient Engagement for Pharma and Social Media

As we wait for the anticipated guidance from FDA regarding the use of social media by the pharmaceutical industry, one of the many aspects discussed as been that of patient engagement with the industry.  The Internet is highly utilized for … Continue reading

Posted in Social Media | 3 Comments

Sunset on the ROI of Social Media and Pharma Discussion

While many pharma companies have developed a wide and deep footprint in social media, many others have not.  When exploring the issue of whether or not to involve a brand, there are several questions to consider.  Some are very important … Continue reading

Posted in Social Media | 4 Comments

OPDP Issues Untitled Letter Involving Social Media

Sort of. There is, of course, a difference between a regulatory action letter that is issued because of a social media use and a regulatory action letter that is issued the communication happens to involve a social media platform.  In … Continue reading

Posted in Social Media, Warning Letters | 1 Comment

Looking Back Down the Road – What Have We Learned from FDA on Regulation of Digital Media?

So last week there was a lot of interest and commentary on the issuance of a draft guidance by FDA that provided some insight into how the agency is regulating promotional speech and social media platforms.  It seemed like a … Continue reading

Posted in FDA Policy, Social Media | 1 Comment

FDA Reveals More Thinking on Social Media

Don’t judge a book by its cover – or in this case, title. In November 2009, FDA held a two-day public meeting on the Promotion of FDA-Regulated Medical Products Using the Internet and Social Media to collect input for the … Continue reading

Posted in Social Media | 3 Comments